Pharmaceutical manufacturing relies on the core tenets of quality, safety, and efficacy. Batch release represents a critical component of this assurance process, and this meticulously controlled ...

TORONTO, Nov. 11, 2025 /PRNewswire/ -- In this free webinar, learn about an alternative automated immunoassay technology and how it performs compared to traditional ELISA. Attendees will discover how ...

There’s nothing more disastrous for a pharmaceutical company than having to recall a batch of medication. Over the years, companies have recalled drugs for many reasons such as the presence of ...

Bulk harvest release testing for adventitious viruses is an integral part of biosafety for manufacturing biopharma products. Finding a testing strategy that works for diverse biologics modalities ...

Mycoplasma infection acts as an invisible killer in the biopharmaceutical industry, compromising drug safety and patient health on a continuous basis. As the industry progresses, mycoplasma testing ...